Carmat: Invest Securities upgrades to 'buy'.

(CercleFinance.com) - Invest Securities has raised its recommendation on Carmat shares from 'subscribe' to 'buy', with a slightly reduced target price from 13 to 12 euros.


Invest Securities has updated its model following the success of the capital increase.
The broker believes that the funds raised will enable Carmat to support sales growth in the commercial and clinical environment, and to strengthen its leeway for obtaining new, longer-term financing.

Thus, "despite low financial visibility, we are confident in the group's ability to strengthen its cash position over the longer term, and the planets are aligned to boost the share price in 2024", concludes the analyst.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.